The impact of subtotal pancreatectomy on people with congenital hyperinsulinism and their caregivers.
Long-term follow-up reveals that surgery for severe infant low blood sugar doesn't cure the condition, challenging surgical approaches and highlighting need for better support.
This first comprehensive study of long-term outcomes after subtotal pancreatectomy for diffuse congenital hyperinsulinism (n=34, median follow-up 9 years) documents high rates of diabetes (44%), pancreatic insufficiency (41%), and persistent hypoglycemia—fundamentally challenging the concept of surgical cure and quantifying the life-long metabolic burden facing patients and their caregivers. Qualitative interviews revealed significant caregiver mental health burden and variability in surgical decision-making, supporting calls for standardized preoperative criteria and better post-surgical support infrastructure.
What the study was
- Study design
- Mixed-methods study using HI Global Registry data and qualitative interviews
- Population
- Individuals with diffuse congenital hyperinsulinism who underwent ≥75% pancreatectomy (n=34); 13 completed qualitative interviews
- Sample size
- 34
- Category
- Other
- Maturity
- Validated
- Journal
- Frontiers in endocrinology
Why it surfaced
First registry-based long-term outcome study of pancreatectomy for diffuse congenital HI; definitively establishes that surgery is non-curative with major long-term morbidity in a rare pediatric disease with limited evidence base, informing surgical decision-making and post-operative counseling.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.